These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 18559495

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen.
    Sabnis G, Schayowitz A, Goloubeva O, Macedo L, Brodie A.
    Cancer Res; 2009 Feb 15; 69(4):1416-28. PubMed ID: 19190349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.
    Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM.
    Cancer Res; 2005 Jun 15; 65(12):5380-9. PubMed ID: 15958587
    [Abstract] [Full Text] [Related]

  • 6. Understanding resistance to endocrine agents: molecular mechanisms and potential for intervention.
    Sabnis G, Brodie A.
    Clin Breast Cancer; 2010 Feb 15; 10(1):E6-E15. PubMed ID: 20133251
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo.
    Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG.
    Carcinogenesis; 2008 Nov 15; 29(11):2162-8. PubMed ID: 18632754
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Xenograft models for aromatase inhibitor studies.
    Brodie A, Sabnis G, Macedo L.
    J Steroid Biochem Mol Biol; 2007 Nov 15; 106(1-5):119-24. PubMed ID: 17611101
    [Abstract] [Full Text] [Related]

  • 13. Aromatase resistance mechanisms in model systems in vivo.
    Brodie A, Macedo L, Sabnis G.
    J Steroid Biochem Mol Biol; 2010 Feb 28; 118(4-5):283-7. PubMed ID: 19778610
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatment.
    Sabnis G, Goloubeva O, Gilani R, Macedo L, Brodie A.
    Mol Cancer Ther; 2010 Jan 28; 9(1):46-56. PubMed ID: 20053764
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aromatase inhibitors and breast cancer.
    Macedo LF, Sabnis G, Brodie A.
    Ann N Y Acad Sci; 2009 Feb 28; 1155():162-73. PubMed ID: 19250202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.
    Brodie AH, Jelovac D, Long B.
    J Steroid Biochem Mol Biol; 2003 Sep 28; 86(3-5):283-8. PubMed ID: 14623522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.